肥胖人群全膝关节置换术中患者特异性器械的成本效用随机试验
该随机对照试验纳入体重指数大于30的骨关节炎行初次全膝关节置换术患者,比较患者特异性器械与标准器械的成本效用。结果显示,从医疗 payer 角度,患者特异性器械被标准器械支配(更贵且效果更差);从社会角度,增量成本效用比为每获得一个质量调整生命年11230.00美元,在50000美元支付意愿阈值下具有成本效果,但净效益分析显示在任何支付意愿值下均无显著成本效果。
要点
- 肥胖患者TKA中,PSI从医疗 payer 角度更贵且效果更差。
- 社会角度ICUR为每QALY 11230.00美元,低于50000美元阈值。
- 净效益分析显示PSI在任何支付意愿值下均无显著成本效果。
核心结论
- 肥胖人群TKA中广泛采用PSI可能在经济上不具吸引力或临床指征不明确。
研究设计与样本
- 随机对照试验,纳入BMI大于30的骨关节炎行初次TKA患者,随机分为标准器械组或PSI组。
主要发现
- 从医疗 payer 角度,PSI被标准器械支配(更贵且效果更差)。
- 从社会角度,增量成本效用比为每QALY 11230.00美元。
- 净效益分析显示,从两种角度在任何支付意愿值下PSI均无显著成本效果。
关键数值与推荐
- 社会角度增量成本效用比为每QALY 11230.00美元,在50000美元支付意愿阈值下具有成本效果。
临床怎么用
- 在肥胖患者TKA中,选择PSI需谨慎考虑其经济性,因医疗 payer 角度不具成本效果。
局限性
- 需未来比较两组长期临床结局和影像学对线。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patient-specific instrumentation (PSI) has been introduced in total knee arthroplasty (TKA) with the goal of increased accuracy of component positioning by custom fitting cutting guides to the patient's bony anatomy. A criticism of this technology is the associated cost. The purpose of this randomized controlled trial was to determine the cost-utility of PSI compared with standard of care (SOC) instrumentation for TKA in an obese population. METHODS: Patients with body mass index greater than 30 with osteoarthritis and undergoing primary TKA were randomized to SOC or PSI. Patients completed a health care resource use diary and the EuroQol-5D at three, six, nine, and 12 months and the Western Ontario and McMaster Universities Osteoarthritis Index at three and 12 months postsurgery. We performed cost-utility and cost-effectiveness analyses from public health care payer and societal perspectives. RESULTS: One hundred seventy-three patients were included in the analysis with 86 patients randomized to PSI and 87 to SOC. PSI was dominated (more costly and less effective) by SOC from a health care payer perspective. From a societal perspective, an incremental cost-utility ratio was calculated at $11,230.00 per quality-adjusted life year gained, which is cost-effective at a willingness to pay threshold of $50,000. Net benefit analyses found PSI was not significantly cost-effective at any willingness to pay value from either perspective. CONCLUSION: Our results suggest that widespread adoption of PSI may not be economically attractive or clinically indicated. Future considerations are to compare long-term clinical outcomes and radiographic alignment between the groups.
引用
- Zomar BO, Vasarhelyi EM, Somerville LE, et al. A Randomized Trial Investigating the Cost-Utility of Patient-Specific Instrumentation in Total Knee Arthroplasty in an Obese Population. J Arthroplasty. 2021. PMID: 34053752. doi:10.1016/j.arth.2021.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。